Public Profile

Predicine, Inc.

Predicine, Inc., a leading player in the precision medicine industry, is headquartered in the United States, with significant operations across key regions globally. Founded in 2015, the company has rapidly established itself as a pioneer in genomic profiling and liquid biopsy technologies, focusing on oncology and other critical health areas. Predicine's core offerings include advanced genomic testing services and innovative biomarker solutions that enable personalised treatment strategies for cancer patients. What sets Predicine apart is its commitment to integrating comprehensive genomic data with clinical insights, enhancing the accuracy of diagnostics and therapeutic decisions. With a strong market position, Predicine has achieved notable milestones, including collaborations with major pharmaceutical companies and contributions to groundbreaking research in cancer treatment. The company continues to drive advancements in precision medicine, making significant strides in improving patient outcomes.

DitchCarbon Score

How does Predicine, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

19

Industry Benchmark

Predicine, Inc.'s score of 18 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Predicine, Inc.'s reported carbon emissions

Predicine, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or climate commitments outlined. Without concrete figures or initiatives, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the industry. As such, further information on their sustainability practices or future commitments would be necessary to provide a comprehensive overview of their climate strategy.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Predicine, Inc.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Predicine, Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Predicine, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Was this information valuable to you?

Similar Organizations

BillionToOne, Inc.

US
Other business services (74)
Updated about 1 month ago

Genosity Inc.

US
Updated about 1 month ago

Personalis

US
Health and social work services (85)
Updated 3 days ago

Guardant Health

US
Research and development services (73)
Updated 2 days ago

Inivata Limited

GB
Health and social work services (85)
Updated 2 months ago
DitchCarbon Score

Labcorp Drug Development Inc.

US
Research and development services (73)
Updated 2 months ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers